Lifecore Biomedical, Inc. \De\ (LFCR) Net Equity Issued and Repurchased (2011 - 2025)

Lifecore Biomedical, Inc. \De\'s Net Equity Issued and Repurchased history runs 12 years deep, the most recent figure standing at -$8000.0 for Q2 2025.

• In Q2 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$8000.0; the TTM figure through May 2025 stood at $23.8 million (up 13498.88% YoY), while the FY2025 annual figure was $23.8 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q2 2025 stood at -$8000.0, down from $17000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $23.8 million in Q4 2024, with the low at -$178000.0 in Q1 2023.
• The 3-year median for Net Equity Issued and Repurchased is $1000.0 (2024), against an average of $4.7 million.